Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
  1. 424B5 Offering Prospectus
  2. 424B5 Offering Prospectus
  3. 424B5 Offering Prospectus
  4. 424B5 Offering Prospectus
  5. 424B5 Offering Prospectus
  6. 424B5 Offering Prospectus
  7. 424B5 Offering Prospectus
  8. 424B5 Offering Prospectus
  9. 424B5 Offering Prospectus
  10. 424B5 Offering Prospectus
  11. 424B5 Offering Prospectus
  12. 424B5 Offering Prospectus
  13. 424B5 Offering Prospectus
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. S-3/A Offering Registration Statement
  16. 424B5 Offering Prospectus
  17. UPLOAD Other SEC-generated Letter
  18. S-3 Offering Registration Statement
  19. 424B5 Offering Prospectus
  20. 424B3 Offering Prospectus

Page 1 of 6 · 104 filings